A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Name: A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
License: Public Domain

NSABP Foundation Inc

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

colo-rectal cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417527
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.